
Blackhawk Growth Corp. (OTC:BLRZF), an investment holding company focused on acquiring and developing high-growth companies in the health, cannabis and psychedelics sectors in the US and Canada, announced it intends to complete a spin-out transaction of its wholly-owned subsidiaries MindBio Therapeutics Pty. Ltd. and Digital Mind Technology Pty Ltd. through a plan of arrangement under the Business Corporations Act (British Columbia).
The new settlement would group the shares of both Australian-based companies together to form an independent company focusing on the psychedelics and mental health technologies business.